Seattle Genetics (SGEN) Misses Q4 EPS by 5c
Tweet
Share
E-mail
Get Alerts SGEN Hot Sheet
Price: $228.74 --0%
Financial Fact:
Research and development: 92.71M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development: 92.71M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Seattle Genetics (NASDAQ: SGEN) reported Q4 EPS of ($0.39), $0.05 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $105.3 million versus the consensus estimate of $105.02 million.
GUIDANCE:
Seattle Genetics sees FY2017 revenue of $405-445 million.
For earnings history and earnings-related data on Seattle Genetics (SGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
